Company / Profit Margin
Gilead Sciences Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
28.9%
FY2025
5-year range
0.5% / 28.9%
FY2021-FY2025
Trend
+1630.5%
vs FY2024
Sector context
#19 of 146
Health Care
What the data says
Profit Margin changed +1631% YoY in FY2025, a notable deviation from the 9-year average annual change of +1159%.
Based on SEC 10-K filings.
28.9% in FY2025 with a 5-year CAGR of +28.4%. Top quartile in the Health Care sector.
Improved from 22.8% to 28.9% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +28.4pp
- 5-Year Change
- +28.4pp
- 10-Year Change
- -
Sector benchmark
Top 13% in Health CareTop 13% of 146This company 28.9% Sector average -796.3%
▼
+103.6% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 1630.5% year-over-year.
- Currently 825.2pp above the Health Care sector average.
- Peak profit margin was recorded in FY2017.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 28.9% | +1630.5% |
| FY2024 | 1.7% | -92.7% |
| FY2023 | 22.8% | +4460.0% |
| FY2022 | 0.5% | -97.9% |
| FY2021 | 24.0% | +4698.0% |
| FY2020 | 0.5% | -97.2% |
| FY2019 | 17.7% | -60.1% |
| FY2018 | 44.4% | -19.9% |
| FY2017 | 55.5% | +14.1% |
| FY2016 | 48.6% | -12.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026